Retro-inverso neurotrophic and analgesic peptides

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 14/475 (2006.01) A61K 38/18 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2300221

Retro-inverso peptide analogs derived from the active neurotrophic region of saposin C. The saposin C-derived peptides (prosaptides) induce neurite outgrowth in vitro, prevent programmed cell death, induce myelination and have an analgesic effect. They are useful in the treatment of central and peripheral nervous system disorders and pain management. The retro-inverso peptides are significantly more resistant to metabolic degradation than the corresponding non-inverted peptides.

La présente invention concerne des analogues de peptide rétro-inverse dérivés de la région neurotrophique active de la saposine C. Les peptides dérivés de la saposine C (prosaptides) produisent une excroissance de neurite in vitro, empêchent la mort cellulaire programmée, entraînent la myélinisation et ont un effet analgésique. Ces peptides sont utilisés dans le traitement des troubles du système nerveux périphérique et dans la gestion de la douleur. Ces peptides rétro-inverses sont significativement plus résistants à une dégradation métabolique que les peptides non inverses correspondants.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Retro-inverso neurotrophic and analgesic peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Retro-inverso neurotrophic and analgesic peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Retro-inverso neurotrophic and analgesic peptides will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1705398

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.